Aprile Vol.2 N° 1 - 2006 - Salute per tutti

10
U. Bauer
8. Cattelan AM, Bauer U, Trevenzoli M, Sasset L,
Campostrini S, Facchin C, Pagiaro E, Gerzeli S, Cadrobbi
P, Chiarelli A. Use of polylactic acid implants to correct
facial lipoatrophy in human immunodeficiency virus 1-positive
individuals receiving combination antiretroviral therapy.
Arch Dermatol. 2006; 142(3):329-34.
5. Burgess CM, Quiroga RM. Assessment of the safety and
efficacy of poly-L-lactic acid for the treatment of HIV-associated
facial lipoatrophy. J Am Acad Dermatol. 2005;
52(2):233-9.
etture consigliate
L 1. Dieterich DT. Long-term complications of
nucleoside reverse transcriptase inhibitor therapy AIDS
Read 2003; 13:176
2. James J, Carruthers A, Carruthers J. HIV-associated
facial lipoatrophy. Dermatol Surg 2002; 28:979
3. Lemperle G, Romano JJ, Busso M. Soft tissue augmentation
with artecoll: 10-year history, indications, techniques,
and complications. Dermatol Surg 2003; 29:573
4. Narins RS, Brandt F, Leyden J, Lorenc P, Rubin M, Smith S.
A randomized, double-blind, multicenter comparison of the
efficacy and tolerability of Restylane versus Zyplast for the
correction of nasolabial folds. Dermatol Surg 2003; 29:588
5. Amard P, Saint-Marc T, Katz P. The effects of polylactic
acid as therapy for lipodystrophy of the face. Antivir Ther
2000; 5:76. Abstract P94
6. Valantin MA, Aubron-Olivier C, Ghosn J, Laglenne E,
Pauchard M, Schoen H. Polylactic acid implants (New Fill)
to correct facial lipoatrophy in HIV-infected patients: results
of the open-label study VEGA. AIDS 2003; 17:2471
7. Jones DH. Injectable silicone for facial lipoatrophy.
Cosmet Dermatol 2002; 15:13
8. Orentreich D. Liquid injectable silicone: techniques for
soft tissue augmentation. Clin Plast Surg 2000; 27:595
9. Conrad K, Reifen E. Gore-Tex implant as tissue filler in
cheek-lip groove rejuvenation. J Otolaryngol 1992; 21:218
10. Lemperle G, Morhenn V, Charrier U. Human histology
and persistence of various injectable filler substances for
soft tissue augmentation. Aesth Plast Surg 2003; 27:254
11. Hwang K, Han JY, Kim DJ. Dermofat graft in deep
nasolabial fold and facial rhytidectomy. Aesthetic Plast
Surg 2003; 27:254
12. Vert M, Li SM, Garreaw H. Attempts to map the structure
and degradation characteristics of aliphatic polyesters
derived from lactic and glycolic acids. J Biomater Sci Pulm
Ed 1994; 6:639
Journal of Plastic Dermatology 2006; 2, 1
13. Lombardi T, Samson J, Plantier F, Husson C, Kuffer R.
Orofacial granulomas after injection of cosmetic fillers.
Histopathological and clinical study of 11 cases. J Oral
Pathol Med 2004; 33:115
14. Administration USFaD. Policy on importing unapproved
AIDS drugs. Vol. 2004, 1988
15. Lever WF, Schaumburg-Lever G. Non-infectious granulomas.
In: Histopathology of the Skin, 8th ed. Lippincott-
Raven, Philadelphia, 1997; p 317
16. Collins E, Wagner C, Walmsley S. Psychosocial impact
of the lipodystrophy syndrome in HIV infection. AIDS Read
2000; 10:546
17. Horl HW, Feller AM, Biemer E. Techique for liposuction
fat reimplantation and long-term volume evaluation
by magnetic resonance imaging. Ann Plast Surg 1991;
26:248
18. Moyle G. Lipodsytrophy: lack of agreement on definition
and etiology presents a challenge to research and therapy
AIDS Read 2002; 12:440-442.
19. Hartmann M, Petzoldt D. Lipodystrophy syndrome in
HIV infection. Hautarzt 2000; 51:159
20. Lupton JR, Alster TS. Cutaneous hypersensitivity reaction
to injectable hyaluronic acid gel Dermatol Surg 2000;
26:135
21. Ziya Saylan MD. Facial fillers and their complications
Aesth Surg 2003; 23:221
22. Gruber PR, Hall ES, Kolstad JH, Iwen ML, Benson RD,
Borchardt RL, inventors. Continuous process for manufacture
of lactide polymers with controlled optical purity. US
patent 5142023. 1992
23. Micard V, Guilbert S. Int J Biol Macromolecules 2000;
27:216-229.
24. Hartman MH. Biopolymers from renewable resources.
In. Kaplan DL (eds), Berlin: Springer-Verlag; 1998. p 367
25. Cutright DE, Hunsuck EE. Tissue reaction to
biodegradable polylactic acid suture. Oral Surg 1971;
31:134
26. Kulkarni RK, Pani KC, Neuman C, Leonard F.
Polylactic acid for surgical implants. Arch Surg 1966;
93:839
27. Polo R, Ortiz M, Babe J, Martinez S, Madrigal P,
Gonzalez-Munoz M. The effects of polylactic acid in the therapy
for the lipoatrophy of the face. Program and abstracts of
the 3rd International Workshop on Adverse Drug Reactions
and Lipodystrophy in HIV; October 23-26, 2001; Athens,
Greece Antiviral Ther 2001; 6:68. Abstract 101
28. New-Fill [package insert]. Luxembourg: Biotech
Industry SA; 2004